Jun 12 |
Should You Buy the Dip on Compass Pathways Stock?
|
Jun 10 |
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
|
Jun 9 |
After FDA setback, psychedelic drugmakers distance themselves from a pioneer
|
Jun 5 |
Psychedelic Drug Stocks Plummet On FDA Advisers' Doubts About Ecstasy Candidate
|
Jun 5 |
Psychedelic stocks fall as FDA panel rejects MDMA therapy
|
Jun 4 |
FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD (updated)
|
May 31 |
Psychedelic stocks mixed as FDA comments on MDMA therapy (update)
|
May 23 |
Psychedelics Closer To Commercialization; Compass Far And Away The Leader
|
May 21 |
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
|